18 results
Summary of dosing recommendations in renal impairment of commonly used hypoglycaemic agents

#Diabetes #Diabetic #Medications #Pharmacology #Dosing
hypoglycaemic agents ... Diabetes #Diabetic #Medications ... #Pharmacology # ... Renal #Impairment ... #CKD #Table #GFR
Pain Assessment and Management Initiative (PAMI) - Non-Opioid Analgesics - Agents and Dosing

#Management #Pain #Pharmacology #NonOpioid
Non-Opioid Analgesics - Agents ... and Dosing #Management ... #Pain #Pharmacology ... NonOpioid #Analgesics #Medications ... #Table #PAMI
Pain Assessment and Management Initiative (PAMI) - Muscle Relaxants - Agents and Dosing

#Management #Pain #Pharmacology #Muscle
Muscle Relaxants - Agents ... and Dosing #Management ... #Pain #Pharmacology ... Relaxers #Relaxants #Medications ... #Table #PAMI
Pain Assessment and Management Initiative (PAMI) - Nerve Blocks - Nerve Distribution, Agents and Dosing Table
Distribution, Agents ... and Dosing Table ... #Pain #Pharmacology ... Nerve #Blocks #Medications ... #Table #PAMI
Pain Assessment and Management Initiative (PAMI) - Neuropathic Pain Medications:

Agent, Initiation Dose and Max Dosages

 -
Assessment and Management ... : Agent, Initiation ... #Pain #Pharmacology ... #Doses #Dosing ... #Table #PAMI
Oral anti-hypertensives with relative fast onset of action (Hypertensive Emergency)

The key concern with oral antihypertensive agents
antihypertensive agents ... antihypertensive agent ... Hypertensive #Emergency #Management ... #Pharmacology # ... Table #BloodPressure
Oral Antihypertensive Medications - Selection by Comorbidities
Comorbidities: 
 • Stable Angina, HFpEF, HFrEF, AFib, TAA/Marfan, Aortic
Medications - Selection ... Dissection • CKD, DM ... Antihypertensive #Medications ... Comorbidities #pharmacology ... #table #management
Pain Assessment and Management Initiative (PAMI) - Intranasal and Nebulized Medications- Agents and Dosing

#Management #Pain #Pharmacology
- Agents and Dosing ... #Management # ... Pain #Pharmacology ... #Doses #Dosing ... #Table #PAMI
DPP4 Inhibitors - Normal and Renal Dosing

Increase Incretins (GLP-I & GIP) -> Stimulates Insulin, Inhibits Glucagon
DPP4 Inhibitors - Normal ... and Renal Dosing ... #Dosing #Pharmacology ... #Management #Diabetes ... #DM2 #Endocrinology
Managing warfarin INR

Warfarin dosage must be individualized according to the patient's response to the drug, and
#management #algorithm ... #pharmacology # ... #table #pharmacotherapy ... #decisionaid #cardiology ... hematology #warfarin #dosing